Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @hemedoc
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @hemedoc
-


Yes! Absolutely deserved. @ninashah33https://twitter.com/theMMRF/status/1207255146994032641 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Marc Fornes
@theverymany, who created Under Magnitude, a permanent installation at the Orange County Convention Center, says the work triggers comparisons based on viewer background. Hence the reason I can’t believe this isn’t the endoplasmic reticulum, esp w the#ASH19 nucleus.pic.twitter.com/ipCHJntBc2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aaron Logan, MD, PhD proslijedio/la je Tweet
Lucky to be part of such an all-star family from
@UCSFCancer at#ASH19 - I’m sure the # of physicians and # of ribbons on our badges will continue to grow each year! (My life goal = ’Dance party organizer’ ribbon some day)pic.twitter.com/KjLKmJcTa3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Another shot of the endoplASHmic reticulum at
#ASH19pic.twitter.com/yda0W0RuFZ – mjesto: OCCC West Concourse
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Bye,
#ASH19. Going to miss the ASHoplasmic reticulum.pic.twitter.com/2ZoN9e05lw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ASH19#bmtsm Horowitz: NMDP/CIBMTR developing Donor Optimization Transplant Success (DOTS) system to give donor suitability score based on other variables besides HLA matching.pic.twitter.com/IDVrTwF0N5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ASH19#bmtsm Horowitz: “By coincidence, the 100,000th transplant facilitated by the@CIBMTR is occurring today.”pic.twitter.com/4WmxO8SgSU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ASH19#bmtsm Horowitz: when donor age implicated in outcomes, field shifted to selecting mostly donors <35yo. None of these studies could have been done without CUBMTR registry and they have had significant impact on patient outcomes.pic.twitter.com/2ocuRzgygj
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ASH19#bmtsm Horowitz: DP typing has become more common due to finding of importance of DP mismatch permissivity. Now ~65% have DP typing obtained. Big change in just 8 years.pic.twitter.com/693RnxwZwz
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ASH19#bmtsm Horowitz: iterative understanding of the importance of high resolution HLA typing for donor selection came from work with CIBMTR database. Clearly impacted standard of care practicespic.twitter.com/ItgmWX1j9c
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ASH19#bmtsm Horowitz: in 2004 the CIBMTR, including registry. Other registries exist. “Registries are part of BMT culture.” CIBMTR now has data on >500,000 patients. ~1300 peer-reviewed publications have been facilitated by CIBMTRpic.twitter.com/cCohsrK2rs
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ASH19#bmtsm Horowitz: the BMT field realized long ago that every question can’t feasibly be addressed in trials. The@CIBMTR registry has become invaluable.pic.twitter.com/biAM3svXQa
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ASH19#bmtsm Horowitz:@bmtdata What do real-world data and real-world evidence actually mean?pic.twitter.com/of3tqpK4fS
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aaron Logan, MD, PhD proslijedio/la je Tweet
Agree. QUAZAR a game-changer in non-transplant eligible AML. Question now is whether post transplant CC486 maintenance improves outcome as well. AMADEUS trial now recruiting rapidly through UK IMPACT trials network
@impactstemcell@AnthonyNolanHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aaron Logan, MD, PhD proslijedio/la je Tweet
This is why we are working tirelessly for
#equaloutcomesforall@CIBMTR@BeTheMatchhttps://twitter.com/Jmarksloan/status/1068852494904827908 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aaron Logan, MD, PhD proslijedio/la je Tweet
Baseline cognitive impairment is associated with inferior OS due to NRM in 330 patients undergoing allogrneic transplant in a multicenter retrospective study led by Dr.
@ROlinMD. Median age 63(range 50-77 years).#geriheme#ASH19pic.twitter.com/F5pKlr9ADm
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aaron Logan, MD, PhD proslijedio/la je Tweet
#ASH19 saved best for last - another truly “practice changing” abstract - QUAZAR study (presented by Andrew Wei) showing clear benefit to CC-486 maintenance in CR1 in older non-transplant eligible AML patients treated intensively. Particular benefit in those MRD+ at enrollment.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ASH19#leusm Iacobucci: summary of a lot of data presented (couldn’t keep up...
)pic.twitter.com/bzXST7jyhY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ASH19#leusm Iacobucci: this analysis also identified several genetic subgroups of MDSpic.twitter.com/Oc9DW4l1Ff
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ASH19#leusm Iacobucci: compound mutations could be explored in this rich dataset, eg, shown here in NPM1 mutant AML/MDS. NPM1 with cohesin mutations have quite favorable prognosis. In CBF AML MN1 overexpression identifies high risk subgroup.pic.twitter.com/WJXpzWNFzv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.